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Abstract
Objective: To determine the changes in smoking habit among patients with oral squamous cell carcinoma (OSCC) 
diagnosed and treated in the Service of Stomatology (Valencia University General Hospital. Valencia, Spain).
Material and methods: The study involved 123 patients with a history of OSCC interviewed by telephone on their 
smoking habits at the time of the diagnosis and modifications in habits subsequently. The mean age at diagnosis 
was 60 years and 9 months (standard deviation, SD ± 12 years and 2 months). Males predominated (61.8%) over 
females (38.2%). The mean time from the diagnosis of OSCC to the survey was 4 years and 6 months (SD ± 3 
years and 6 months).
Results: Almost one-half of the patients (45.5%) were active smokers at the time of the diagnosis, with a mean 
duration of the habit of 34.9 years (SD ± 12 years and 7 months). In turn, 19.5% of the patients were ex-smokers at 
diagnosis, with an average of 13 years and 9 months (SD ± 9 years and 4 months) from smoking cessation to the 
development of cancer. A total of 57.1% of the smokers abandoned the habit at diagnosis, 8.9% continued to smoke 
to the same extent as before, and 33.9% reduced smoking.
Conclusion: A full 44.4 % of our patients diagnosed with OSCC continued to smoke despite warnings of the risks, 
and although the majority claimed to have reduced their smoking habit, interventional strategies would be indi-
cated to help ensure complete smoking cessation. 
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Fig. 1. Association between smoking and cancer in different 
organs.
* The IARC (International Agency for Research on Cancer) 
considers that there is sufficient evidence of a causal relation-
ship between smoking and liver cancer.
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Introduction
The association between tobacco smoking and can-
cer is one of the most important paradigms in modern 
epidemiology (Fig. 1). Malignant tumors of the oral 
cavity represent about 3% of all malignancies, and of 
these, 90% correspond to oral squamous cell carcinoma 
(OSCC). The estimated incidence is 5.1 cases / 100,000 
inhabitants/year (1). Although a number of factors have 
been related to the etiopathogenesis of oral malignan-
cies (alcohol, human papilloma virus, Epstein-Barr vi-
rus, a lack of fruit and vegetables in the diet, periodon-
tal disease, genetic factors) (2), smoking is the main risk 
factor associated with oral cancer, and particularly with 
OSCC (3). The prevalence of OSCC in cigarette smokers 
is estimated to be 4-7 times greater than in non-smokers 
(4). This circumstance represents the third most signifi-
cant association between smoking and cancer, follow-
ing lung cancer (hazard ratio: 15.0-30.0) and laryngeal 
cancer (hazard ratio: 10.0) (5). According to Petti, 25% 
of all oral malignancies are attributable to both smoked 
and chewed tobacco (6), and the risk of oral, pharyngeal 
and esophageal cancer begins to be significantly higher 
in smokers starting from levels as low as two cigarettes 
a day. This indicates that there is no harmless level of 
smoking (7).
The existence of an undeniable link between smoking 
and OSCC reasonably should lead to total smoking ces-
sation among patients who have been diagnosed with 
the disease and who have been duly informed of its 
seriousness, of the role played by tobacco, and of the 
important risk of tumor relapse if smoking continues. 
Unfortunately, this is not the case, and many patients 
continue to smoke despite such considerations.
The main objective of the present study was to deter-
mine the changes in smoking habit in a group of 123 pa-
tients diagnosed with OSCC and treated in the Service 
of Stomatology (Valencia University General Hospital. 
Valencia, Spain).
Material and Methods
The study was carried out in the Service of Stomatology 
(Valencia University General Hospital. Valencia, Spain) 
between February and May 2009, following approval by 
the Clinical Research Ethics Committee of the hospital. 
The study included a total of 123 patients with a his-
tologically confirmed diagnosis of OSCC, and with a 
mean time from diagnosis to the study interview of 4 
years and 6 months (SD ± 3 years and 6 months; range 
3-166 months). The mean patient age at the time of the 
diagnosis was 60 years and 9 months (SD ± 12 years 
and 2 months; range 25-92 years). There were 76 males 
(61.8%) and 47 females (38.2%).
A telephone interview was made to document informa-
tion on the smoking habit at the time of the diagnosis, 
the duration of the habit, and the daily consumption 
rate. The patients were also asked about their smoking 
habit at the time of the interview, and whether they had 
stopped smoking at some point. In the case of patients 
that did not smoke at the time of the diagnosis, the inter-
view was completed by asking them whether they had 
ever smoked in the past. All the patients initially agreed 
to participate in the study (n = 130). However, 7 of them 
could not be contacted by telephone. As a result, the 
final sample consisted of 123 patients (loss rate 5.4%).
Only patient reported smoking habit was considered, 
without biochemical validation in the form of cotinine 
determination in saliva, urine or blood.
The data were coded, tabulated and analyzed using the 
SPSS version 15.0 statistical package (SPSS®, Chicago, 
IL, USA). For data analysis, use was made of the bino-
mial test for differences of absolute values, the Pearson 
chi-squared test for the comparison of proportions, and 
the Student t-test for the comparison of means.
Results
(Table 1) shows the most relevant epidemiological and 
clinical characteristics of the study sample. At the time 
of diagnosis, 45.5% of the patients (n = 56) were ac-
tive smokers. Of these, 67.9% consumed more than one 
packet of cigarettes a day (20 cigarettes per packet). The 
mean duration of the smoking habit up until the devel-
opment of OSCC was 34 years and 9 months (SD ± 12 
years and 7 months), with a range of 6-59 years. This 
duration was significantly shorter in females (25 years 
and 8 months (SD± 9 years and 3 months) than in males 
(36 years and 8 months (SD ± 12 years and 5 months) 
(ts = 2.61; p<0.05), despite the absence of gender differ-
ences in the number of cigarettes smoked daily. In ad-
dition, 24 patients (19.5%) were ex-smokers at the time 
of the diagnosis. The mean duration of the habit in these 
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Table 1. Clinical and epidemiological data on oral cancer patients according to smoking habit.
Smoking at diagnosis Smoker Non-smoker Total Significance
56 (45.5%) 67 (54.5%) 123 
Age (mean and SD) 
53 years and 7 
months (SD ± 9 
years) 
66 years and 8 months 
(SD ± 11 years and 4 
months) 
60 years and 9 months 
(SD ± 12 years and 2 
months) 
<0.05
Gender Male 46  (82.1%) 30  (44.8%) 45.5% <0.05Female 10  (17.9%) 37  (55.2%) 
Location
(&)
Gums 10  (17.9%) 17  (25.4%) 22% N.S. 
Tongue 25  (44.6%) 16  (53.7%) 49.6% N.S. 
Cheek mucosa  5     (8.9%)   8  (11.9%) 10.6% N.S. 
Floor of mouth  9   (16.1%)   3    (4.5%) 9.8% <0.05
Palate  3     (5.4%)        2     (3%) 4.1% N.S. 
Lip           0   1     (1.5%) 0.8% N.S. 
>1 location  3     (5.4%) 0 2.4% N.S. 
Time from 1st symptom to 1st
consultation 
5 months and 5 days 
(SD ± 7 months and 
1 day) 
4 months and 4 days 
(SD ± 4 months and 28 
days) 
4 months and 21 
days (SD ± 6 
months) 
        N.S. 
Stage (*) 
I 30  (53.6%) 44  (65.7%) 74  (60.2%) N.S. 
II 10  (17.9%) 13  (19.4%) 23  (18.7%) N.S. 
III   4    (7.1%)   3   (4.5%)   7    (5.7%) N.S. 
IV  10  (17.9%)         4   (6%)       14  (11.4%) <0.05
Reason for 
consultation 
Casual finding  11  (19.6%)  11 (16.4%)  17.7% N.S. 
Nonspecific
discomfort   6  (10.7%)          4   (6.0) 8.1% N.S. 
Ulcer 27  (48.2%) 27  (40.3%) 43.9% N.S. 
Lump (tumor)   7  (12.5%) 14  (20.9%) 17.1% N.S. 
Pain   3    (5.4%)   6    (9.0%) 7.3% N.S. 
White spot   2    (3.6%)   4    (6.0%) 4.9% N.S. 
Bleeding 0   1   (1.5%) 0.8% N.S. 
patients was 27 years and 1 month (SD ± 14 years and 
8 months), with a range of 4-48 years. The mean time 
elapsed from smoking cessation to the appearance of 
OSCC was 13 years and 7 months (SD ± 9 years and 4 
months), with a range of 6 months to 30 years.
There were no significant differences in terms of the 
location of the tumor, with the exception of the floor of 
the mouth, which was more often affected in smokers 
than in non-smokers (Table 1).
Most of the patients (78.9%) were diagnosed in early 
stages of the disease (I and II), while 17.1% were di-
agnosed in advanced stages (III and IV). Tumor stage 
could not be determined in 5 patients. The number of 
patients diagnosed in stage IV was significantly greater 
Table 2. Changes in smoking habit.
The values within the heavy broken line correspond to patients who reduced or suppressed smoking.
Smoking at time of diagnosis of OSCC 
No 1-10cig/day 
11-20
cig/day 
21-40
cig/day 
41-60
cig/day 
>60
cig/day Total
Smoking at 
time of 
interview 
No 66(53.7%) 
8 (6.1%) 6 
(4.9%) 
11
(8.9%) 
7 (5.7%) 0 98(79.7%) 
1-10 cig/day 0 1 (0.8%) 3 (2.4%) 
5 (4.1%) 2 (1.6%) 0 11(8.9%) 
11-20 dig/day 0 0 0 4(3.3 %) 
1 (0.8%) 1 (0.8%) 6 (4.9%) 
21-40 cig/day 1 (0.8%) 0 0 3 (2.4%) 3 (2.4%) 0 7 (5.7%) 
41-60 cig/day 0 0 0 0 1 (0.8%) 0 1 (0.8%) 
>60 cig/day 0 0 0 0 0 0 0 
Total
67
(54.5%) 
9 (7.3%) 9 
(7.3%) 
23
(18.7%) 
14
(11.4%) 
1 (0.8%)  
123
Med Oral Patol Oral Cir Bucal. 2010 Sep 1;15 (5):e721-6.                                                                                                                                                          Smoking and oral cancer antecedents 
e724
among smokers than in non-smokers (Table 1).
There were no differences in terms of the initial reason 
for consultation between smokers and non-smokers.
The modifications in smoking habit after cancer diag-
nosis are reported in (Table 2). A little over one-half of 
the smokers (57.1%; n = 32) stopped smoking after the 
diagnosis, while 42.9% (n = 24) continued to smoke. By 
gender, a full 80% of the female smokers abandoned 
the habit, versus only 52.2% of the males - the differ-
ence being statistically significant (Zs = 2.51; p<0.05). 
Among the patients who continued to smoke, only 5 
continued to do so to the same extent as at the time of 
diagnosis, while the rest reduced their smoking habit. 
One patient began to smoke after the diagnosis of the 
disease. We found that the greater the smoking habit at 
the time of the diagnosis, the lower the percentage of 
smoking cessation (Table 3).
Discussion
The persistence of modifiable risk factors in patients 
who have already suffered cancer is associated to high 
disease relapse risk and to serious limitations in the ef-
ficacy of treatment. However, the modification of cer-
tain habits is clearly difficult. According to Jazieh et al. 
(8), less than a quarter of all patients with antecedents 
of cancer (mean age 68 years) modified their habit in a 
positive way. Smoking tobacco generates addiction as a 
result of its nicotine content, which acts upon the central 
nervous system, causing both physical and psychologi-
cal dependency. This in turn gives rise to compulsive 
consumption despite the negative health consequences 
and the fact that most smokers express a desire to reduce 
or stop smoking entirely. The effect of nicotine upon the 
dopamine-related pleasure pathways of the central nerv-
ous system, and its special pharmacokinetic character-
istics (with a time to effect of just 10 seconds, followed 
by rapid dissipation), lead smokers to seek continuous 
dosing throughout the day (9). The literature abounds 
with strategies designed to abandon the habit, includ-
ing behavioral therapies (from self-assisting materials 
to cognitive-behavioral therapy) and drugs. The latter 
are based on nicotine replacement treatments (patches, 
chewing gum, sprays, inhalers), antidepressants (bu-
propion) and varenicline (10). In a systematic review of 
the interventions designed to facilitate the cessation of 
non-smoked tobacco use, no significant benefits were 
observed in terms of pharmacological treatment (bu-
propion, nicotine patches and nicotine chewing gum). 
As regards the behavioral interventions, statistical het-
erogeneity was observed: 6 of the 12 evaluated trials 
reporting significant benefits, while four reported a 
nonsignificant tendency towards benefit, and two found 
no effects (11).
The success of smoking intervention strategies is largely 
dependent upon the adequate optimization of resources. 
To this effect, it is very important to adequately identify 
the corresponding target populations. Patients who have 
already suffered oral cancer undoubtedly represent a 
strategic population in this context. The persistence 
of smoking habit after the diagnosis of head and neck 
cancer influences both treatment efficacy and patient 
survival. In patients with head and neck malignancy 
diagnosed in stages III and IV, survival after two years 
is poorer among those who continue to smoke than in 
those who either do not smoke or have abandoned the 
habit after diagnosis of the disease (39% versus 66%), 
according to the data published by Browman et al. (12). 
In that same study, the authors also found the radiother-
apy complete response rate to be lower among patients 
who smoke during the treatment than in those who do 
not smoke.
There is evidence of the association between persist-
ent smoking habit and an increased frequency of sec-
ond primary head and neck tumors. Twenty-five years 
ago, Silverman et al. (13) explored this association in 
160 patients with antecedents of the disease who were 
followed-up on for an average of 4 years and 11 months 
(range 1-15 years). The authors found the greatest risk 
of second primary malignancies (29.7%) to correspond 
to patients who failed to modify their smoking habit, 
while a drastic decrease was noted among those who 
reduced or abandoned smoking. This suggests the need 
for a sustained minimum smoking threshold in order 
to cause cancer. The sample in the study published by 
Silverman et al. (13) was similar to our own in terms of 
mean age (58 versus 60 years in our series), gender dis-
tribution (44% females versus 38%) and preferential tu-
mor location in the tongue (43.8% versus 44.6%). How-
Table 3. Smoking cessation according to smoking at the time of the diagnosis 
of OSCC.
Smoking at 
diagnosis
No. patients 
at diagnosis 
No. patients at 
interview 
% smoking 
cessation 
1-10 cig/day 9 1 88.9% 
11-20 cig/day 9 3 66.7% 
21-40 cig/day 23 12 47.8% 
41-60 cig/day 14 7 50% 
>60 cig/day 1 1 0% 
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ever, there were differences in the amount of tobacco 
consumed (86% heavy smokers, i.e., over one packet of 
cigarettes/day, versus 66.7%) and in the percentage of 
smokers at diagnosis (73% versus 45.5%). In contrast to 
our study, the mentioned authors included nasopharyn-
geal, oropharyngeal and laryngeal cancers in their se-
ries. In their group of 117 smokers followed-up on dur-
ing 1-15 years, 32% of the patients did not modify their 
smoking habit, 23% reduced smoking, and 45% stopped 
smoking. Percentage smoking cessation was compara-
tively higher in our study (57.1%). Likewise, 33.9% of 
our patients reduced their smoking habit, while 8.9% 
continued to smoke as much as before. The lesser per-
centage smoking cessation reported by Silverman et al. 
(13) may possibly be related to the greater percentage of 
heavy smokers in their series. In accordance with our 
own observations, heavy smokers (over one packet of 
cigarettes a day) show lower cessation rates than those 
patients who smoke less than one packet of cigarettes a 
day (44.7% versus 77.8%).
Do et al. (14), in a randomized chemical prevention 
study involving 13-cis-retinoic acid in early-stage head 
and neck cancer, conducted a longitudinal sub-study to 
assess the correlation between smoking-related second 
primary tumors and cigarette smoking habit in 1190 pa-
tients diagnosed with stage I and II squamous cell car-
cinoma of the upper airway and digestive tract. They 
found that 12.7% of the patients had never smoked – in 
strong contrast to the 35% in our own series. A total 
of 55.1% of their patients remained non-smokers at the 
time of the evaluation; this was slightly higher than the 
45.4% recorded in our study. In turn, the above authors 
found 12.3% of their patients to start smoking after the 
diagnosis, versus only 0.8% in our series (a single pa-
tient). Their recorded hazard ratio for second primary 
tumors was 2.75 (confidence interval 1.49-5.07) among 
the patients who continued to smoke versus those who 
had never smoked. The mean duration of follow-up was 
similar in both studies (4 years and 6 months versus 4 
years and 10 months).
Some authors have reported data in contrast to the 
above. Tomek and McGuirt (15) found no differences 
in a group of 91 patients with second primary head and 
neck tumors between those who continued to smoke af-
ter the diagnosis and those who stopped smoking. In 
that study, 88 of the 91 patients with second primary 
head and neck tumors were smokers at the time of the 
diagnosis of the first tumor – thus evidencing a clear 
association between smoking and the appearance of 
second primary tumors. These data are very similar to 
those published by Schwartz et al. (16).
In our study no protocolized strategy was used to pro-
mote smoking cessation among the patients other than 
the provision of information on the importance of ces-
sation in relation to the prognosis of the disease. In a 
controlled trial carried out by Gritz et al. (17), compari-
sons were made of the efficacy of a structured interven-
tion program that included physician counseling to stop 
smoking, written material and reinforcement sessions, 
versus an intervention similar to our own. The authors 
found no significant differences in smoking habit be-
tween the two groups one year after the intervention. 
One of the reasons given by the authors to explain the 
lack of efficacy was the high smoking cessation rate 
in the control group (76.8%). However, some publica-
tions (18) have reported similar cessation rates without 
any type of protocolized intervention (67.3%). In our 
study, percentage smoking cessation was 51.7%, though 
it must be underscored that the average follow-up was 
4 years and 6 months versus only one year in the two 
studies commented above.
Compared with other health professionals, dental sur-
geons have a more precise notion of the smoking hab-
its of their patients. However, over 40% of all dental 
surgeons fail to systematically ask their patients about 
smoking, and 60% do not systematically recommend 
smoking cessation (19). 
In conclusion, 44.4% of all patients diagnosed with 
OSCC continue to smoke despite warnings about the 
risks involved, and although the majority claim to have 
reduced smoking, intervention measures are needed to 
help ensure complete and permanent smoking cessation 
in view of the risk of tumor relapse and the appearance 
of new lesions even with low levels of tobacco use.
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